sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Apr-2015 07:58
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 1003.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 11-Dec-2014
International Journal of Infectious Diseases
Middle East respiratory syndrome coronavirus unlikely to reach epidemic status
In three new studies in the International Journal of Infectious Disease, researchers reported on clinical outcomes in the Kingdom of Saudi Arabia, how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there. An editorial in the same issue discusses how the relatively high percentage of infections has been hospital-acquired, which reduces the possibility that MERS-CoV will reach pandemic or even epidemic status.

Contact: Fiona Macnab
Elsevier Health Sciences

Public Release: 11-Dec-2014
Scientists closing in on an new type of vaccine
When we acquire diarrhea on a vacation, it is often caused by a bacterial infection. Now a Danish research team is working on a new type of vaccine design targeting the disease causing bacterium -- if it works it may very well revolutionize not only the prevention of this disease, but also offer protection against other pathogens with a heavy disease burden such as Mycobacterium tuberculosis and antibiotic-resistant Staphylococcus aureus (MRSA). The project is supported with a 2.93 million DKK Novo Pre-Seed grant (393.677 €) from Novo Seeds, which is part of the Novo Nordisk Foundation and Novo A/S as well as the University of Southern Denmark's internal Proof of Concept Board.
Novo Nordisk Foundation, University of Southern Denmark

Contact: Birgitte Svennevig
University of Southern Denmark

Public Release: 11-Dec-2014
Maternal and Child Health Journal
Poor diet links obese mothers and stunted children
Malnutrition is a major cause of stunted growth in children, but new UCL research on mothers and children in Egypt suggests that the problem is not just about quantity of food but also quality.

Contact: Harry Dayantis
University College London

Public Release: 10-Dec-2014
Environmental Science & Technology Letters
How long can Ebola live?
The Ebola virus travels from person to person through direct contact with infected body fluids. But how long can the virus survive on glass surfaces or countertops? How long can it live in wastewater when liquid wastes from a patient end up in the sewage system? In an article published in the journal Environmental Science & Technology Letters, Kyle Bibby of the University of Pittsburgh reviews the latest research to find answers to these questions.

Contact: Cara Masset
University of Pittsburgh

Public Release: 10-Dec-2014
Journal of Biological Chemistry
New Notre Dame study examines important Ebola protein
A new study by Robert Stahelin, an adjunct associate professor of chemistry and biochemistry at the University of Notre Dame and an associate professor at the Indiana University School of Medicine-South Bend, as well as a member of Notre Dame's Eck Institute for Global Health, investigates how the most abundant protein that composes the Ebola virus, VP 40, mediates replication of a new viral particle.

Contact: Robert Stahelin
University of Notre Dame

Public Release: 9-Dec-2014
International Journal of Infectious Diseases
Guidelines for treatment of Ebola patients are urgently needed
As the Ebola Virus Diseases epidemic continues to rage in West Africa, infectious diseases experts call attention to the striking lack of treatment guidelines. With over 16,000 total cases and more than 500 new infections reported per week, and probable underreporting of both cases and fatalities, the medical community still does not have specific approved treatment in place for Ebola, according to an editorial published in the International Journal of Infectious Diseases.

Contact: Fiona Macnab
Elsevier Health Sciences

Public Release: 9-Dec-2014
Lancet Infectious Diseases
Simeprevir-based therapy offers cost-effective alternative in treatment of hepatitis C
Researchers at Penn Medicine, in collaboration with an international team, have shown that a protease inhibitor, simeprevir, along with interferon and ribavirin is as effective in treating chronic Hepatitis C virus infection as telaprevir with interferon and ribavirin, the standard of care in developing countries. Further, simeprevir proved to be simpler for patients and had fewer adverse events. The complete study is online and is scheduled to publish in January 2015 in The Lancet Infectious Diseases.
Janssen Research and Development

Contact: Lee-Ann Donegan
University of Pennsylvania School of Medicine

Public Release: 9-Dec-2014
Bayer and DNDi sign agreement to develop an oral treatment for river blindness
Bayer HealthCare and the Drugs for Neglected Diseases initiative have signed an agreement under which Bayer will provide the active ingredient emodepside to support DNDi in its effort to develop a new oral drug to treat river blindness (or onchocerciasis). The world's second leading infectious cause of blindness, river blindness is a neglected tropical disease caused by a filarial worm.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 9-Dec-2014
ACS Nano
Nanotechnology against malaria parasites
Malaria parasites invade human red blood cells; they then disrupt them and infect others. Researchers at the University of Basel and the Swiss Tropical and Public Health Institute have now developed so-called nanomimics of host cell membranes that trick the parasites. This could lead to novel treatment and vaccination strategies in the fight against malaria and other infectious diseases. Their research results have been published in the scientific journal ACS Nano.

Contact: Olivia Poisson
University of Basel

Public Release: 9-Dec-2014
Genome Research
Using genome sequencing to track MRSA in under-resourced hospitals
Whole genome sequencing of MRSA from a hospital in Asia has demonstrated patterns of transmission in a resource-limited setting, where formal screening procedures are not feasible.

Contact: Sarah Collins
University of Cambridge

Public Release: 9-Dec-2014
International Journal of Epidemiology
Experts call for faster mobilization of 'overlooked' survivors to contain Ebola epidemic
In an editorial published online today in the International Journal of Epidemiology, experts from the Departments of Psychiatry and Epidemiology at Columbia University, New York, are calling for survivors of the Ebola epidemic to be mobilised in a bid to hasten containment of the disease.

Contact: Kirsty Doole
Oxford University Press

Public Release: 9-Dec-2014
Genome Research
Genome sequencing traces MRSA spread in high transmission setting
Methicillin-resistant Staphylococcus aureus is a common cause of hospital-acquired infections, with the largest burden of infections occurring in under-resourced hospitals. While genome sequencing has previously been applied in well-resourced clinical settings to track the spread of MRSA, transmission dynamics in settings with limited infection control is unknown. In a study published online today in Genome Research, researchers used genome sequencing to understand the spread of MRSA in a resource-limited hospital with high transmission rates.
Medical Research Council, Wellcome Trust, NIHR Cambridge Biomedical Research Centre

Contact: Peggy Calicchia
Cold Spring Harbor Laboratory

Public Release: 8-Dec-2014
Annals of Global Health
Asbestos: An ongoing challenge to global health
Challenges to global health can evolve from policies and decisions that take years or decades to unfold. An article in the current issue of the Annals of Global Health describes the current state of asbestos use worldwide, a story that began over 100 years ago, and the real and contrived controversies regarding asbestos.

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 8-Dec-2014
Each dollar spent on kids' nutrition can yield more than $100 later
There are strong economic incentives for governments to invest in early childhood nutrition, reports a new paper from the University of Waterloo and Cornell University. Published for the Copenhagen Consensus Centre, the paper reveals that every dollar spent on nutrition during the first 1,000 days of a child's life can provide a country up to $166 in future earnings.

Contact: Pamela Smyth
University of Waterloo

Public Release: 8-Dec-2014
Rapid Ebola test is focus of NIH grant to Rutgers scientist
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola. Alland and Cepheid previously used technology similar to the planned Ebola test to develop a rapid test for tuberculosis that is now widely used in impoverished areas of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rob Forman
Rutgers University

Public Release: 8-Dec-2014
Combining insecticide sprays and bed nets 'no more effective' in cutting malaria
There is no need to spray insecticide on walls for malaria control when people sleep under treated bed nets, according to new research by Durham University and the Medical Research Council's Unit in The Gambia.
Medical Research Council

Contact: Steve Lindsay
Durham University

Public Release: 8-Dec-2014
Nature Cell Biology
A pill for obesity?
Harvard Stem Cell Institute researchers at Harvard and Massachusetts General Hospital have taken what they are describing as 'the first step toward a pill that can replace the treadmill' for the control of obesity -- though it of course would not provide all the additional benefits of exercise. The researchers have already identified two compounds that can accomplish that in human cells.

Contact: B. D. Colen
Harvard University

Public Release: 5-Dec-2014
International Journal of Biomedical Engineering and Technology
Stick out your tongue
The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help a physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue.

Contact: Albert Ang
Inderscience Publishers

Public Release: 4-Dec-2014
Nature Communications
UCLA study: To stop spread of HIV, African governments should target hot zones
To stop the spread of HIV in Africa, researchers at UCLA, using a complex mathematical model, have developed a strategy that focuses on targeting 'hot zones,' areas where the risk of HIV infection is much higher than the national average.

Contact: Mark Wheeler
University of California - Los Angeles

Public Release: 4-Dec-2014
Ebola rapid response
The National Science Foundation has awarded the first of a number of rapid response grants to advance fundamental Ebola research. The grants will support researchers seeking to answer important questions about the virus's fundamental nature, how it interacts with other substances, how it spreads, and how communication and perception affect public safety during an epidemic.
National Science Foundation

Contact: Sarah Bates
National Science Foundation

Public Release: 4-Dec-2014
PLOS Pathogens
Blood pressure build-up from white blood cells may cause cerebral malaria death
Intracranial hypertension -- increased blood pressure inside the head -- can predict a child's risk of death from malaria. A study published on Dec. 4 in PLOS Pathogens reports that accumulation of white blood cells impairs the blood flow out of the brain and causes blood pressure increases in mice with experimentally induced cerebral malaria.
Dana Foundation, National Institutes of Health

Contact: Ute Frevert

Public Release: 4-Dec-2014
Friendly bacteria are protective against malaria
In a breakthrough study to be published on the Dec. 4 issue of the prestigious scientific journal Cell, a research team led by Miguel Soares at the Instituto Gulbenkian de Ciencia discovered that specific bacterial components in the human gut microbiota can trigger a natural defense mechanism that is highly protective against malaria transmission.
Bill and Melinda Gates Foundation, Fundano para a Ciencia e a Tecnologia, European Research Council

Contact: Ana Mena
Instituto Gulbenkian de Ciencia

Public Release: 3-Dec-2014
Parasite researcher wins international malaria medal
Melbourne researcher professor Alan Cowman has won the Sornchai Looareesuwan Medal 2014 for his significant contributions to understanding how the malaria parasite causes disease and for his search for potential malaria vaccines.

Contact: Alan Gill
Walter and Eliza Hall Institute

Public Release: 3-Dec-2014
Volunteers can now help scientists seek Ebola cure in their (computer's) spare time
Beginning today, anyone can download a safe and free app that will put their computer or Android-based mobile device to work to form a virtual supercomputer to help The Scripps Research Institute screen millions of chemical compounds to identify new drug leads for treating Ebola. Meanwhile, the devices will remain fully available for normal use by their owners.

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 2-Dec-2014
Novel nanoparticle technology to be used to screen for Ebola virus in saliva
Ceres Nanosciences will work with George Mason University and the United States Army Medical Research Institutes of Infectious Diseases to assess the ability of the Nanotrap technology to develop a more sensitive and safer Ebola virus detection method that uses saliva instead of blood.
Bill & Melinda Gates Foundation

Contact: Michele McDonald
George Mason University

Showing releases 226-250 out of 1003.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>